2026年5月20日，长风药业股份有限公司（股票代码：02652）在公告中披露，于当日在香港联交所场内回购普通股合计32,000股，占当日前已发行股份约0.0106%。本次回购价格介乎每股20.00港元至20.52港元，总涉资约64.69万港元。
回购完成后，公司已发行股本总数维持302,223,586股，其中流通股301,372,086股，库存股851,500股。公司于2025年12月16日通过购回授权，总回购额度为30,222,358股，截至本次回购后已回购股份累计851,500股，占授权总额的约0.2817%。公司同时确认所有回购事项已符合香港联交所上市规则及相关法律规定。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.